Literature DB >> 14759785

The potential role of aprotinin in the perioperative management of malignant tumors.

Ara A Vaporciyan1, Joe B Putnam, W Roy Smythe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14759785     DOI： 10.1016/j.jamcollsurg.2003.09.022

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  4 in total

1.  Effect of anti-fibrinolytic therapy on experimental melanoma metastasis.

Authors:  Jennifer M Kirstein; Kevin C Graham; Lisa T Mackenzie; Danielle E Johnston; Leslie J Martin; Alan B Tuck; Ian C MacDonald; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-12-12       Impact factor: 5.150

2.  A possible association between aprotinin and improved survival after radical surgery for mesothelioma.

Authors:  Peter H Norman; Peter F Thall; Ronaldo V Purugganan; Bernhard J C J Riedel; Dilip R Thakar; David C Rice; Lisa Huynh; Wei Qiao; Sijin Wen; W Roy Smythe
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

3.  Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.

Authors:  Efstratios Apostolakis; Nikolaos Panagopoulos; Efstratios N Koletsis; James Crockett; Helen Stamou-Kouki; Efrosini Sourgiadaki; Kriton Filos; Dimitrios Dougenis
Journal:  J Cardiothorac Surg       Date:  2008-03-24       Impact factor: 1.637

4.  [Surgical Treatment of Refractory Chest Tumors Assisted 
by Cardiopulmonary Bypass].

Authors:  Rongying Zhu; Shanzhou Duan; Wentao Yang; Li Shi; Fuquan Zhang; Yongbing Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.